Form 8-K - Current report:
SEC Accession No. 0001104659-26-049485
Filing Date
2026-04-27
Accepted
2026-04-27 16:43:50
Documents
13
Period of Report
2026-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2612861d1_8k.htm   iXBRL 8-K 26508
2 EXHIBIT 99.1 tm2612861d1_ex99-1.htm EX-99.1 9836
6 GRAPHIC tm2612861d1_ex99-1img01.jpg GRAPHIC 4527
  Complete submission text file 0001104659-26-049485.txt   211895

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20260427.xsd EX-101.SCH 3002
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20260427_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20260427_pre.xml EX-101.PRE 22350
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2612861d1_8k_htm.xml XML 3280
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 26901689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)